Bausch Health US LLC
Bridgewater, NJ
- UEI
- G1L1GBQUTGH5
- CAGE
- 8CBY8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- SBMXTF4GPEZ2
- Z1CCNW3HQ655
- Bausch & Lomb Incorporated · Rochester, NY YZMGWLFTN2S7
- Valeant Pharmaceuticals International Corporation HJZ8TJUF1CF1
-
- SAM.gov registration date
- Physical address
- 400 Somerset Corporate Blvd, Bridgewater, NJ 08807, USA
- Website
- bauschhealth.com
- Founded
- 1959
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Equipment & Supplies
- Eyewear
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $209,901 |
| FY2025 | $131,740 |
| FY2024 | $274,750 |
| FY2023 | $142,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $209,901 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Fraxel FTX laser | Veterans Integrated Service Network 8 (VHA) | $184,000 | |
| Vaser liposuction | Veterans Integrated Service Network 22 (VHA) | $25,901 | |
| Medical equipment maintenance services | Defense Health Agency | $21,340 | |
| Liposuction system | Medical Command (Army) | $99,900 | |
| FY24 new buy liposuction sys 0012075125-3 eamc | Medical Command (Army) | $132,500 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Iridex Corp | Mountain View, CA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Surgical | Rochester, NY | 339112 Surgical and Medical Instrument Manufacturing |
| Lumenis BE, Inc. | San Jose, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Boston Scientific Corp | Marlborough, MA | 339112 Surgical and Medical Instrument Manufacturing |
| Or Elder Inc. | New York, NY | 423460 Ophthalmic Goods Merchant Wholesalers |
About the company
Bausch Health US LLC, a New Jersey-based pharmaceutical and medical device manufacturer, operates as a prime contractor supplying specialized medical equipment, surgical instruments, pharmaceuticals, and dermatological laser systems to the Department of Veterans Affairs and the Defense Health Agency on full-and-open federal purchase orders and supply schedules. Bausch Health does not pursue set-asides and competes exclusively in unrestricted procurement. The vendor operates through a parent-subsidiary structure that includes Bausch & Lomb Incorporated, Solta Medical Inc., Valeant Pharmaceuticals International Corporation, and Pedinol Pharmacal Inc., each contributing distinct capability domains to the federal footprint.
Bausch Health's federal portfolio spans pharmaceutical preparation manufacturing, surgical and medical instrument manufacturing, surgical appliances and supplies, and electromedical apparatus manufacturing. Representative capability work includes a $184 thousand firm fixed price purchase order from Veterans Integrated Service Network 8 for a Fraxel FTX laser system (October 2026), a $99.9 thousand purchase order from the Defense Health Agency for a VASERlipo 2.2 ultrasonic liposuction system supporting operative services at Brooke Army Medical Center (May 2025), and a $132.5 thousand purchase order from the Defense Health Agency for a liposuction system at Fort Eisenhower, Georgia (August 2024). Beyond individual purchase orders, Bausch Health holds a $3.68 billion Federal Supply Schedule contract under GSA Schedule 65 I B (Drugs, Pharmaceuticals, & Hematology Related Products) effective through September 30, 2031, and a $530 thousand single-award Blanket Purchase Agreement with the VA National Acquisition Center for ammonium chloride and calcium disodium versenate through October 2027.
Customer concentration remains dominated by the Veterans Affairs system. The VA Veterans Integrated Service Network 12 anchors the portfolio with three awards carrying $5.29 billion in combined potential value — substantially all from the FSS Schedule vehicle rather than individual purchase orders. The Defense Health Agency places the second-highest award count (four purchase orders, $364 thousand combined potential value) but at far lower per-transaction magnitude. The VA National Acquisition Center, VISNs 8, 6, and 1 round out the active set, each placing one to two smaller purchase orders. The two customer rankings diverge sharply: by count, the Defense Health Agency competes with VISNs; by dollars, the VA's GSA Schedule contract dwarfs all other activity.
Bausch Health's vehicle footprint centers on the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), which carries four task orders valued at $788 thousand in combined potential value. The FSS Schedule contract represents the strategic anchor — the $3.68 billion ceiling reflects multi-year, multi-agency ordering potential across federal healthcare facilities served through VA networks and Defense Health Agency medical treatment facilities nationwide. Individual purchase orders flow against the schedule pricing rather than through competitive delivery-order competitions.
Activity is modest in volume and flat in trajectory: three awards in 2022, one in 2023, two in 2024, two in 2025, and three in 2026. The vendor faces minimal recompete exposure in the next twenty-four months — only two awards (combined potential value $210 thousand) reach ultimate completion before October 2027, and both represent small-dollar maintenance or supply replenishment orders rather than major vehicle recompetes. The FSS Schedule contract's base period runs through September 2031, insulating the largest potential-value award from near-term recompete pressure.
Bausch Health operates exclusively as a prime contractor with no subcontract footprint in the source data. The medical device and pharmaceutical portfolio demonstrates vertical integration across manufacturing, distribution, and direct federal sales without reliance on prime subcontracting relationships.
Quick answers
Is Bausch Health US LLC registered in SAM.gov?
Yes. Bausch Health US LLC's SAM.gov registration is active through September 3, 2027.
Which contract vehicles does Bausch Health US LLC hold?
Bausch Health US LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Bausch Health US LLC received in federal contracts?
Federal contracts obligated $131,740 to Bausch Health US LLC in fiscal year 2025 and $758,391 in fiscal years 2023 through 2027.
What is Bausch Health US LLC's most recent federal award?
Bausch Health US LLC's most recent federal contract award is Fraxel FTX laser (36C24826P1335), from Veterans Integrated Service Network 8 (VHA), on October 1, 2026.
On GovTribe
See Bausch Health US LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors